HCM - Takeda wins FDA nod for colorectal cancer therapy
2023-11-09 07:21:50 ET
More on HUTCHMED, Takeda, etc.
- Takeda Pharmaceutical Company Limited (TAK) Q2 2023 Earnings Call Transcript
- Takeda: Why I'm Staying Bearish On This Generic Drug Dividend Play
- Hutchmed: Progressing, But We Would Like More Clarity On Profit Margins
- Takeda Pharmaceutical gives H1 results, raised FY guidance
- Takeda fails in second Phase 3 trial for CPF therapy Alofisel
For further details see:
Takeda wins FDA nod for colorectal cancer therapy